Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Performance of Biomerieux Vitek MS Prime for Mycobacteria Identification

ASM Microbe 2024

American Society for Microbiology

Atlanta, GA, June 13-17, 2024

Poster presentation: Performance of Biomerieux Vitek MS Prime for Mycobacteria Identification

Authors: Shier KL, Rayala AM, Eshete BG, Bao JR, Price TK

Specialty: Infectious disease

Related content

Test FAQ
T-SPOT®.TB
Test FAQ
QuantiFERON TB Gold Plus
Publication
Prevalence of Hepatitis B Virus and Latent Tuberculosis CoInfection in the United States
Conference Presentation
Automation of Blood Sample Processing for T-SPOT®.TB Assay with Extended Blood Sample Stability: A Validation Study
Conference Presentation
Evaluating Testing Patterns and Prevalence Estimates of Hepatitis B Virus and Latent Tuberculosis Co-Infection from 2016 to 2020: A National Clinical Laboratory Database Analysis

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.